Join Faeth Therapeutics for a virtual event to discuss topline results from its Phase 2 PIK-201 trial exploring PIKTOR in advanced endometrial cancer.

The event will feature key opinion leader and PIK-201 principal investigator David Starks, MD, MPH (Gynecologic Oncologist, Avera Cancer Institute), who will join company management to provide clinical perspectives on the unmet need and evolving treatment landscape in advanced endometrial cancer.

A live question and answer session will follow the formal presentations.